Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
04/2011
04/28/2011US20110098282 New compounds
04/28/2011CA2776914A1 Diazepan derivatives as modulators of chemokine receptors
04/27/2011CN101092417B Folacin analogue, and salt of folacin analogue in use for medical treatment
04/26/2011US7932255 Controlling cell proliferation
04/26/2011CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use
04/21/2011US20110092698 Novel heterocyclyl compounds
04/21/2011US20110092491 Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase Activity
04/21/2011US20110092489 3-Aryl-Substituted Quinazolones, and Uses Thereof
04/20/2011CN102026987A Therapeutic agent for pain
04/20/2011CN102026986A Hexafluoroisopropanol derivatives
04/19/2011US7928100 Quinolone analogs and methods related thereto
04/13/2011EP2307387A1 Novel heterocyclyl compounds for treatment of cardiovascular disease
04/12/2011US7923444 Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
04/12/2011CA2419768C Amino acid-derived, 7-membered cyclic sulfamides and methods of synthesizing the same
04/07/2011WO2011000945A9 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns
04/07/2011US20110082295 Novel curcumin derivative
04/07/2011US20110082280 Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules
04/06/2011EP2305654A1 Therapeutic agent for pain
04/06/2011EP2303847A1 Synthesis of cyclic amidines
04/06/2011EP1706371B1 Aryl aniline derivatives as beta2 adrenergic receptor agonists
04/06/2011CN102007106A 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
04/06/2011CN102007105A 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
04/06/2011CN102006873A Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
04/05/2011CA2467269C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
03/2011
03/31/2011WO2011036204A1 [1,4]-benzodiazepines as vasopressin v2 receptor antagonists
03/31/2011CA2772284A1 [1,4]-benzodiazepines as vasopressin v2 receptor antagonists
03/30/2011EP2300473A2 Fumarate salt of 4-bromophenyl 1,4-diazabicycloý3.2.2¨nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
03/24/2011WO2011034078A1 Glycine compound
03/24/2011US20110071139 Cycloalkyl Lactame Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1
03/24/2011CA2772689A1 Glycine compound
03/23/2011EP2297118A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives
03/23/2011EP0744435B2 Water-absorbent resin, process for production thereof, and water-absorbent resin composition
03/23/2011CN101987835A Homopiperazine acethydrazide derivatives
03/22/2011US7910577 Injectable nanoparticulate olanzapine formulations
03/22/2011CA2432572C Oxybenzamides derivatives as factor xa inhibitors
03/17/2011US20110065691 Therapeutic piperazines
03/17/2011US20110065690 Compositions and methods for treatment of leukemia
03/17/2011US20110065689 Therapeutic piperazines
03/16/2011EP2295442A2 Inhibitors of interleukin-1beta converting enzyme
03/16/2011EP2295052A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450
03/15/2011CA2407939C Diazacycloalkane derivatives as bleach catalyst and composition and method for bleaching a substrate
03/10/2011WO2011027156A1 Benzodiazepine derivatives for treating hepatitis c infection
03/10/2011US20110059956 Therapeutic agent for pain
03/10/2011US20110059952 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
03/10/2011US20110059043 Chemical compounds
03/08/2011CA2488202C 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
03/08/2011CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors
03/01/2011US7897596 {2-Amino-4-[(4-(4-chlorophenyl)piperidin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic, antidepressant; cardiac disease or disorder, neurological disease or injury, sleep disorder, epilepsy, neuropathic pain, angina
02/2011
02/24/2011WO2011021726A2 Nitrogen-containing compound and pharmaceutical composition
02/24/2011WO2011021676A1 Process for producing benzo[b][1,4]diazepine-2,4-dione compound
02/24/2011WO2011000945A3 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns
02/24/2011WO2010121164A3 1,4-benzodiazepinone compounds and their use in treating cancer
02/24/2011CA2771579A1 Nitrogen-containing compound and pharmaceutical composition
02/24/2011CA2771136A1 Process for producing benzo[b][1,4]diazepine-2,4-dione compound
02/22/2011US7893223 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
02/17/2011US20110040087 Peptide turn mimetics
02/17/2011US20110039833 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists
02/15/2011US7888503 Benzodiazepine derivatives that inhibit rock
02/15/2011US7888349 Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds
02/15/2011US7888348 7-membered ring compound and method of production and pharmaceutical application thereof
02/15/2011CA2461348C [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain
02/15/2011CA2325937C Peptide turn mimetics
02/08/2011CA2480940C Non-steroidal progesterone receptor modulators
02/02/2011CN101962369A Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
02/01/2011US7879834 Spiroindoline modulators of muscarinic receptors
01/2011
01/27/2011WO2010046929A3 Novel polymorphic forms of temazepam and processes for preparing the same
01/27/2011US20110021506 Anthelmintic agents and their use
01/20/2011US20110015158 Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
01/19/2011CN101952259A Benzodiazepine compound and pharmaceutical composition
01/19/2011CN101160290B 7-membered ring compound, process for producing the same, and medicinal use thereof
01/18/2011US7872002 Therapeutic pyrazoloquinoline derivatives
01/18/2011US7871999 Substituted thiazoles and their use for producing drugs
01/13/2011US20110009423 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
01/13/2011US20110009393 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof
01/12/2011EP2190827B1 N-benzyl-n'-arylcarbonylpiperazine derivatives as lxr modulators
01/12/2011CN1856313B Therapeutic compounds
01/12/2011CN101941953A Nitrogenous heterocyclic substituted hydrazide compounds as well as preparation methods and applications thereof
01/11/2011CA2430124C Lactam compounds and pharmaceutical use thereof
01/06/2011WO2011000945A2 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns
01/06/2011US20110003984 Bispidon ligands and the metal complexes thereof
01/06/2011US20110003784 Opsin-binding ligands, compositions and methods of use
01/04/2011US7863266 Therapeutic pyrazoloquinoline urea derivatives
01/04/2011CA2421228C Polyarylcarboxamides useful as lipid lowering agents
01/04/2011CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/2010
12/30/2010US20100331317 Benzodiazepine compound and pharmaceutical composition
12/30/2010US20100331316 5-phenyl-lh-benz0 [e] [1,4] diazepine compounds substituted with an hydroxamic acid group as histone deacetylase inhibitors
12/28/2010US7858614 Therapeutic pyrazolonaphthyridine derivatives
12/22/2010EP2264016A2 A process for producing pure form form of 2-Methyl-4-(4-Methyl-1-Piperazinyl)-10h-thieno[2,3-B][1,5] benzodiazepine
12/22/2010CN1988907B Dual small molecule inhibitors of cancer and angiogenesis
12/22/2010CN1729158B Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
12/22/2010CN101925586A Novel heterocyclic compounds
12/15/2010CN101918375A Benzodiazepinone compounds useful in the treatment of skin conditions
12/14/2010US7851465 Benzodiazepine compounds; controlling cell death, autoimmune diseases; antiinflammatory agents; antiproliferative agents; antiarthritic agents; multiple sclerosis;Crohn's disease; leukemia; inflammatory bowel disorders; anticancer, antitumor agents; asthma; psoriasis
12/14/2010US7851464 Spirolactam aryl CGRP receptor antagonists
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/09/2010US20100311732 Novel heterocyclic compounds
12/08/2010EP2258682A2 Amino-substituted tricyclic derivatives and methods of use
12/08/2010EP2257534A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257533A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
12/08/2010EP2257297A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 60